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Synthetic polymers, nanoparticles, and carbon-based materials have great potential in applications
including drug delivery, gene transfection, in vitro and in vivo imaging, and the alteration of biolog-
ical function. Nature and humans use different design strategies to create nanomaterials: biological
objects have emerged from billions of years of evolution and from adaptation to their environment
resulting in high levels of structural complexity; in contrast, synthetic nanomaterials result from
minimalistic but controlled design options limited by the authors’ current understanding of the bio-
logical world. This conceptual mismatch makes it challenging to create synthetic nanomaterials
that possess desired functions in biological media. In many biologically relevant applications, nano-
materials must enter the cell interior to perform their functions. An essential transport barrier is the
cell-protecting plasma membrane and hence the understanding of its interaction with nanomaterials
is a fundamental task in biotechnology. The authors present open questions in the field of nanoma-
terial interactions with biological membranes, including: how physical mechanisms and molecular
forces acting at the nanoscale restrict or inspire design options; which levels of complexity to
include next in computational and experimental models to describe how nanomaterials cross bar-
riers via passive or active processes; and how the biological media and protein corona interfere
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with nanomaterial functionality. In this Perspective, the authors address these questions with the
aim of offering guidelines for the development of next-generation nanomaterials that function in
biological media. Published by the AVS. https://doi.org/10.1116/1.5022145
I. INTRODUCTION
Functional nanomaterials are used in many products of
our daily life, from sunscreens to food1 but are associated
with uncontrolled risks such as nanotoxicity and environ-
mental pollution.2 The proper design of “smart” or
“intelligent” nanomaterials that perform a desired function
in living organisms is an appealing, but challenging task: the
complexity of living organisms results from their adaptation
to the environment during billions of years of evolution,
whereas fabrication of synthetic nanomaterials is usually
based on the optimization of a relatively small number of
parameters. By offering precise control of design parameters,
robustness, and simplicity of construction, synthetic nano-
materials can promise new functions that do not yet exist in
the biological world. However, the changes that they induce
in complex biological media and their lack of adaptability
may compromise the design goals due to degradation or lim-
ited biocompatibility. The design of biologically active
nanomaterials therefore requires a clear definition of the
design goals, the conception and implementation of the
material, and methods for testing the materials efficacy.
While essential parameters—size, shape, elasticity, composi-
tion, and surface properties—of nanomaterials have been
identified3–6 and their chemical properties can be precisely
controlled, the major challenges in nanomaterial design arise
in monitoring, understanding, and controlling their interac-
tion with biological media, ranging from specific biological
barriers to the immune system.
Using the prototypical example of a transport of nano-
objects into eukaryotic cells, we map out the difficulties of
nanomaterial design, and elaborate our opinion on how
design obstacles are linked to fundamental questions in
understanding the transport into living cells. We also high-
light starting points for extending experimental and theoreti-
cal models for the prediction of a nanomaterial functionality
in biological environments: what are the next degrees of
increased complexity that are most important to consider? In
Sec. II, we describe where we see the major obstacles for an
optimal design flow that integrates all necessary design
steps. In Sec. III, we focus on challenges in understanding
and exploiting already known mechanisms of nanomaterial
transport across plasma membranes, and in Sec. IV, we pro-
vide examples that highlight how the presence of biological
media challenges theoretical and experimental approaches
but also inspires new design concepts.
II. MISSING LINKS TO BIOLOGICAL CONTEXT
Modern chemistry allows to synthetize a large variety of
nanomaterials with a broad range of architectures (e.g.,
quantum dots, polymers, nanostars, nanorods, nanodisks,
and nanocages), chemical compositions (organic/inorganic,
liquid/solid), and surface properties (e.g., decoration with
ligands and charges).7 A good illustration on recent progress
in advanced synthesis is the possibility of dynamically con-
trolling the number of ligands on 23-gold-atom nanoparticle
within the so-called molecular surgery.8 With fairly high
precision, one can control the chemical composition of nano-
materials, the length and order of synthetic peptide sequen-
ces, and the architecture, chemistry, and length of synthetic
polymers. Yet it is often not clear how chemical properties
translate into physical control parameters when embedded in
highly complex biological media. When coming from a
physical and chemical background, one often focuses on
microscopic mechanisms of nanomaterial interactions with
model environments, such as single component lipid mem-
branes, although the biological context is essential for for-
mulating critical design goals and testing their functionality.
In addition to the extensively discussed protein corona
around nanoparticles,9 more emphasis should be put on the
question of how the protein-crowded environment, cosolvent
properties, ionic strength and ion complexation, or pH mod-
ify the conformation and function of soft objects such as pol-
ymers or nanogels. In turn, the impact of nanomaterials on
the biological environment can be subtle. For example, one
has observed that the band structure of metal oxide-based
nanomaterials is an important factor for their toxicity.
Depending on the band gap, these materials may interfere
with the level of oxidative stress and can thereby be
toxic.10,11
While theoretical and simulation approaches often inves-
tigate populations of identical nano-objects with idealized
properties such as perfectly smooth spherical nanoparticles
or monodisperse polymers, real nano-objects are not so pris-
tine and, for instance, exhibit variations in surface rough-
ness, polydispersity, and heterogeneity within a sample.
Since small differences between nano-objects can be critical
for their interaction with biological media, different fates are
expected already from small variations in their properties,
including decomposition into subpopulations due to the com-
plex nature of the interactions.
Due to the Abbe diffraction limit, it is challenging to gain
a glimpse at the molecular scale in aqueous solution.
However, optical imaging can reveal significant insights into
the impact of nano-objects on membrane properties, such as
membrane morphology,12 dynamics,13 and permeability.14
Furthermore, structural insights can be gained from spectro-
scopic methods.15 Toward the imaging of individual nano-
particles, alternative approaches, such as stimulated
emission depletion microscopy16,17 and electron micros-
copy,18 are applied. Microfluidic and electrochemistry meth-
ods can also be applied together to monitor individual
translocation events of single and clustered nanoparticles
across model lipid membranes.19
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III. CHALLENGES FOR TRANSPORTACROSS
LIPID-BILAYER MEMBRANES
Whereas there is evidence for insertion and translocation
of nano-objects such as cell-penetrating peptides, polymers,
or coated nanoparticles across biological and lipid mem-
branes from experiment and simulation, the thermodynamic
driving forces and the molecular mechanisms for transloca-
tion remain hotly debated.20–23 In analogy to other topology-
altering (Fig. 1) membrane processes, such as fusion, fission,
and pore formation,24 the passage across a membrane can be
roughly subdivided into an initial recognition or docking
stage and the subsequent penetration, as well as the separa-
tion of the object from the membrane. Generally, one may
distinguish between active, assisted and passive transport
across a membrane. Furthermore, one should distinguish
between translocation mechanisms that involve the direct
penetration of the membrane core or pore formation from
endocytic pathways involving the wrapping of nano-objects.
For the design of a nano-object, it is crucial to consider that the
translocation and endocytosis pathways lead to fundamentally
different topological situations.
A. Active transport
Active transport refers to mechanisms that are enabled by
an expenditure of chemical energy. Endocytotic pathways
are widely associated with active processes,25 since in bio-
logical environments dynamin catalyzes the separation step
of an invagination.26,27 Grafting lipoproteins and other
ligands onto nano-objects will make it possible to exploit
active endocytic and phagocytic machineries of cells by
binding to specific membrane receptors in the docking step.
Ion and glucose transporters are other common examples
of protein channels that facilitate active translocation across
a membrane. Proteins that can specifically transport
synthetic nano-objects across a bilayer are missing.
Developing such machinery will be particularly worthwhile
because it has the potential to impart high selectivity onto
translocation. Existing concepts related to passive polymer
translocation through nanopores28 as well as voltage-driven
DNA translocation through biological pores29 can be starting
points for the development of translocation machineries for
nano-objects driven by local chemical energy (adenosine tri-
phosphate). It is thus crucial to more deeply study the mech-
anisms of existing transmembrane transporters and active
lipid flip-flop catalyzing proteins. An interesting avenue of
research could be aimed at identifying the minimal synthetic
analogs or modifications of those proteins that enables them
to bind to nano-objects and subsequently catalyze their trans-
location. Accurately predicting the catalytic role of active
proteins interacting with nanostructures is an open field for
molecular simulation techniques. Intervening in active and
regulatory transport systems can, however, easily show the
fate of over-ambition: A nanomaterial that perturbs active
machineries such as glucose or ion transporters,30,31 or active
lipid exchangers between leaflets, may cause unpredictable
regulatory failures and toxic effects.
B. Assisted transport
Assisted translocation exploits global nonequilibrium
processes or local response of the membrane that facilitate
translocation processes, but that are not directly related to
the translocation mechanism. A prototypical illustration of
global nonequilibrium aspects is a translocation process that
exploits the actively maintained lipid or protein asymmetry
between the inner and outer monolayers. An interesting chal-
lenge is the possible transport of nano-objects driven by
chemical potential differences—for instance, by developing
analogs of secondary transporters. Other examples of
assisted translocation include enhanced permeability at
FIG. 1. Challenges and open questions in transport across a cell membrane.
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boundaries between lipid domains,32,33 the assistance by
near-critical composition fluctuations or raftlike domains,34
as well as interfaces between lipids and membrane-inserted
nano-objects with critical hydrophobicity.35 The adsorption
of nano-objects at the membrane may locally alter the com-
position of the membrane in contact with the nano-object,
and, in turn, facilitate translocation of the object.36
Endocytic pathways are assisted by families of
curvature-inducing proteins that attach to the membrane:
clathrin and bin, amphiphysin, rvs (BAR) proteins.
Anisotropic and Janus nanoparticles can mimic curvature-
inducing proteins,37,38 and promote the formation of invagi-
nations.39 In vitro experiments indicate that so-called
N-BAR proteins, by having a transmembrane domain, pro-
mote endocytosis in the absence of dynamin, while pure
BAR-domains seem to restrict fission but support tubular
shapes.40 On one hand, it is often discussed that specific
assisting mechanisms are required for the final pinch-off to
occur; on the other hand, computer simulations indicate that
spontaneous endocytosis of wrapped nanoparticles also
occurs in cases where N-BAR or equivalent molecules are
not present.41–44 A key question here is how the barriers for
altering membrane topology and concomitant time scales
depend on the object enclosed. To this end, the prediction of
the pinch-off dynamics and time scales can be seen as bench-
mark case for molecular simulation models. It is particularly
challenging to map time scales and free energy barriers
between atomistic and coarse-grained models—motivating
the development of new simulation techniques bridging the
gap. Beside computer simulation, it will be worthwhile to
test existing theoretical models for the pinch-off45,46 and the
role of “universal membrane remodelers”47 via focused
experiments with model membranes. An interesting question
to address is the relation between nano-object size, and the
spontaneous curvature induced by assisting proteins or syn-
thetic analogs: can we predict matching sizes and shapes for
selective transport?
An important aspect of nano-object transport attracting
more attention is the role of cell membrane tension, which is
on the order of 0.01 mN/m in native membranes.48 In many
cases, the underlying actin cortex is also relevant by inducing a
cortical tension on the order of 0.01–1 mN/m.49 Experimental
evidence shows that endocytic efficiency typically decreases
with increasing membrane tension, but for some cell types the
response can be inverted.50 Theoretically, it is expected that
tension-induced restraining forces for particle wrapping appear
for particle sizes larger than a characteristic length scale defined
by the membrane bending rigidity and tension.51 For larger par-
ticles, the degree of wrapping is controlled by the competition
between tension and adhesion.52 The release of membrane res-
ervoirs48 and membrane remodeling53 upon increasing tension
or areas consumed by wrapping complicate the situation.
Before disentangling all contributions in biological environ-
ments, however, it will be interesting to investigate wrapping
and endocytosis as a function of tension in model experiments
with reduced complexity. Membrane tension can also play a
crucial role for translocation pathways across a membrane. The
probability of transient pores induced, for instance, by cell-
penetrating peptides is expected to be sensitive to the ratio
between the tension of the membrane and the line tension of
the pore.54
C. Passive transport
Passive translocation refers to the diffusion of small
(<10 nm) nano-objects across the membrane, which is chiefly
dictated by the properties of the nano-objects and their inter-
actions with the membrane. Passive translocation processes
do not require any external forces or gradients of other com-
ponents between the two sides of the membrane. They are
rather robust, fast, and present a universal platform for devel-
oping translocation approaches. The ratio between nano-
object size and the membrane thickness as well as its geomet-
ric shape are critical parameters.19,56 Additionally, the
mechanical or chemical responsiveness of the nano-object,57
i.e., the deformability, and adaptability of the chemical sur-
face composition and charge determine insertion and translo-
cation. These surface properties of a nano-object can be
controlled, e.g., by grafting polymers onto the surface of the
nano-object.62 In particular, stimuli-responsive coatings with
multicomponent brushes provide ample opportunities to tailor
the passive translocation processes by environmental charac-
teristics such as pH, salt concentration, or temperature.55
Polymers in contact with a membrane may undergo confor-
mational changes such as coil-globule transitions.58,59 It is
suggested that some cell penetrating peptides switch to helical
amphipathic structure in the presence of the membrane.60,61
To design synthetic analogs of these self-assembled peptides
is a challenge.
In addition to passive translocation across the mem-
brane, “passive endocytosis” was also hypothesized63 and
debated over several decades.64 The docking step and
wrapping of nanoparticles has been described theoreti-
cally,51,65 and explored numerically as a function of shape
and adhesion strength of the particle at the membrane.56,66
While an invagination can be driven by adhesion at the
membrane as observed in model experiments,12 it remains
an interesting question to what extent assisted or active pro-
cesses are essential for the final pinch-off of the wrapped
nano-object.
IV. CHALLENGES IN BIOLOGICALLY COMPLEX
MEDIA
Experimental and theoretical studies on the interactions
between synthetic nanomaterials and membranes in biomimetic
or in in vitro cellular systems often assume nano-objects of ide-
alized shape, size, and surface in a simple fluid environment.
Typical solvent environments considered are salt buffers such
as phosphate-buffered saline (PBS) or water with a given con-
centration of monovalent ions. However, biological membranes
are embedded in molecularly crowded aqueous environments,
such as the cytoplasm and extracellular fluids, with distinct sol-
vent conditions and compositional challenges that must be
considered.
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A. Properties of the surrounding media
Ionic components, proteins, or RNA do not only deter-
mine simple physical properties such as pH and the screen-
ing of electrostatic interactions. Very recently, it has been
discovered that several types of proteins together with RNA
give rise to spatially controlled intracellular phase separation
into droplets that are called RNA bodies or granules.67
Similarly, if foreign substances such as macromolecules,
micelles, or nanoparticles are inserted into living systems, it
is very likely that their properties and interactions with the
cell membranes are different from those in simple aqueous
solutions. For instance, bare nanoparticles can adsorb pro-
teins and thus change their surface properties,68 but poly-
mers can also change their properties by adsorbing and
binding components of the biological fluid. For instance, the
puzzling phenomenon of passive translocation of positively
charged arginine-rich peptides, and even of oligoarginines,
was explained by the binding of (counter-)anions from the
buffer.69 Few theoretical and simulation studies have taken
into account complex formation between nano-objects and
other components typical of biological solutions including
counterion binding. The compensation of charge in polymers
such as polypeptides can switch the monomer solubility
from hydrophilic to hydrophobic since in many cases the
uncharged backbone is hydrophobic. If nano-objects are
close to the membrane, this binding process can be further
influenced by the interaction with the membrane in particular
by the charge and counterions located near the lipid head
groups. It must be noted that arginine itself is positively
charged and strongly hydrophilic which should prevent any
passive pathway of these polymers through lipid bilayer
membranes. Arginine-rich peptides such as trans-activator of
transcription or homeoprotein transcription factors appear in
nature and thus are evolutionarily optimized in the presence
of biological fluids. Recently, it was demonstrated that cube-
octameric silsesquioxanes70 with similar positively charged
ligands efficiently translocate through cell membranes.
Experimental evidence thus opens new possibilities for
developing bioinspired cell-penetrating nano-objects, but
also presents a challenge for theory and experiments using
model membranes in artificial environments. A key question
is: how many and which components of extracellular fluids
(if considering the insertion process into the cell) are essen-
tial to mimic a typical extracellular environment in a repre-
sentative way? Is there a standard for such a biological
medium that is elementary enough to retain the advantages
of minimal model systems? Is there a better standard for a
biological medium than the typically used PBS suspensions
(pH 7.4 and physiological salt levels) to study nano-object
membrane interactions? Nanomaterials represent length
scales where the molecular crowding of cellular as well as
intracellular environments substantially influence diffusion
dynamics, excluded volume effects, and intermolecular asso-
ciation.71 A new standard medium should potentially contain
crowding agents such as polyethylene glycol (PEG) or poly-
saccharides in order to simulate those effects.72
Another level of complexity arises when taking into
account dynamically changing environments. As an exam-
ple, during endocytic uptake of nanoparticles, the endosomal
compartment is acidified, which can lead to the protonation
of functional groups on a particle’s surface, changing its net
charge. In the endosome, this change in the pH of the envi-
ronment is coupled with a change in the lipid composition of
the interacting endosomal membrane, which can lead to sig-
nificant changes in the nanomaterial’s ability to disrupt or
cross the membrane.73
Finally, recent attention has been paid to the dynamic
feedback that membranes may induce in biological media
via the recruitment of curvature-sensing proteins. It has been
found that membrane curvature and cortical proteins can
both take part in coupled oscillations of shape and concentra-
tion,74,75 which presumably contribute to cell signaling pro-
cesses. How would a nanomaterial interfere with those
dynamics?
B. Protein corona
In physiological environments, a large number of proteins
and other biomolecules are present. These molecules can
rapidly bind in a temporally complex way to nano-objects,
and form fluctuating coronas around nano-objects that may
have a strong influence on their interactions with a biological
environment.76–79 In analogy with the Vroman effect,80,81
the composition of coronas may vary dramatically over
time.82
Nanoparticles that are immersed in human blood serum
have coronas that consist of proteins such as albumin, immu-
noglobulins, fibrinogen, apolipoproteins, and proteins from
the complement system.9,83,84 There is a large class of pro-
teins called opsonins that label foreign objects to be detected
by the immune system, and trigger the uptake by phagocytes
and macrophages. In contrast, another class of proteins, dys-
opsonins, including albumins and apolipoproteins are known
to inhibit phagocytic uptake.76,85 The composition of both
groups adsorbed at nanocarriers in blood serum controls their
elimination by resident macrophages.86,87 Recent experi-
ments, for instance, seem to explain the so-called stealth
effect of PEG coatings against phagocytosis by the selective
adsorption of lipoproteins and apolipoproteins onto the PEG-
coated nanocarriers.88 However, the hypothesis that
PEGylation of particles increases the binding of dysopsonins
that mask the particles was already put forward more than
15 years ago.89 Since corona formation seems almost
unavoidable, the central challenge is to control its composi-
tion and structure as a function of time.
C. Real biomembranes
Lipid bilayers can be convenient model systems for
nanoparticle-membrane interactions that enable detailed
physical insight to be obtained thanks to their relative struc-
tural simplicity and well-characterized properties. However,
real biological membranes are far more complex in structure,
containing a large amount of both integral and peripheral
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proteins90,91 in addition to a high degree of glycosylation
providing a complex coating with polymeric sugars. Further
complexity is added by the cell membrane’s transmembrane
asymmetry, lateral heterogeneities, and underlying cytoskel-
eton, which is a dynamic network of semiflexible to rigid
polymers. Future theoretical and experimental model sys-
tems should start to take this increased membrane complex-
ity into account in order to understand the true extent to
which a lipid bilayer can model nanoparticle interactions at a
real biomembrane. For example, giant unilamellar vesicles
can be fabricated directly from the plasma membranes of
mammalian cells and are known as giant plasma membrane
vesicles (GPMVs).92 They contain most of the natural com-
ponents of a real cell membrane but without the active pro-
cesses of a real cell. Therefore, these materials are ideal
experimental systems to bridge the gap between model lipid
membranes and the whole cell. Experiments with GPMVs
not only allow the validity of more abstract theoretical and
experimental models to be tested, but can be a starting point
to study the effects of protein and lipid sorting as well as
more specific coupling of nanomaterials with biomolecular
interaction networks. Although structurally impaired com-
pared to GPMVs, planar supported membranes made from
native cell membranes serve as additional model systems,
which allow for a large arsenal of sophisticated surface ana-
lytical tools.93,94
A further challenge arises in the design of nanoparticles
that target a specific cell type. This is particularly important
for nanomedicine applications, where drug-loaded particles
might be targeted to a specific subpopulation of cells pos-
sessing a particular disease pathology. In many disease
states, e.g., cancers, it is known that cells upregulate specific
cell surface receptors such that they are then present in
higher concentrations within the plasma membrane.95
Among many others, well-known examples include growth
factor receptors,96 vitamin receptors such as folate recep-
tors97 and the transferrin receptor.98 Receptor overexpression
is usually heterogeneous within different cells of a single
tumor and also between different patients for a given type of
cancer, posing a fundamental challenge when aiming for
generalized descriptions of molecular and physical mecha-
nisms of how nano-objects engage in receptor binding.
Targeting approaches have involved the attachment of high
affinity ligands to the surface of a nanoparticle that targets
these receptors. However, receptors that are overexpressed
in disease state are also present in the membranes of healthy
cells, albeit at lower concentrations, leaving significant chan-
ces for off-target binding to healthy cells. Therefore, we see
a central challenge to clarify the effect of ligand density on
nano-objects on receptor-mediated uptake. Complementary
to this challenge, the surface density of receptors needs
attention as playing a role for nanoparticle targeting to dis-
eased cells. An additional question for in vitro systems that
are barely addressed in current mechanistic studies, but
likely important to unravel the uptake process of nanopar-
ticles, is the impact of hydrodynamic interactions in biologi-
cal fluid flows on cell-specific adhesion.
V. CONCLUSIONS
In this Perspective, we illustrate the progress and collect
open questions related to the design and function of nanoma-
terials that interact with lipid and biological membranes
(Table I). The minimalistic but well-controlled design
approach used by scientists is conceptually different from
biological adaptation and evolution. The mismatch between
theoretical or experimental models of reduced complexity
and the multitude of interactions concerted within rich bio-
logical environments makes it challenging to design func-
tional materials. There has been substantial progress in all
fields related to nanomaterial transport across membranes,
including the development of theoretical and experimental
models, nanomaterial synthesis, and in vitro testing in sys-
tems with increased biological complexity. Both endocytic
pathways as well as translocation by penetrating through a
bilayer have been extensively analyzed via theoretical
TABLE I. Summary of challenges and open questions.
Challenges Next levels of model complexity.
Missing links to biological context
How do chemical properties translate into
physical control parameters within complex media?
Statistical nature of nano-object properties such as polydispersity,
in-sample variations of surface shape and composition.
Challenges for transport across lipid bilayer membranes
How to exploit protein complexes
for specific nano-object transport?
Include active components in molecular models.
Can we rationalize dynamic barriers for topological
membrane transitions as a function of molecular
composition and curvature-inducing nano-objects?
Systematically study the role of membrane tension
in simulation studies and model experiments.
Challenges in biologically complex media
How to mimic cellular and intracellular fluids
in a representative way? Is there a better standard
for a model biological media than PBS?
Can we control protein coronas as a function of time?
Fluid complexity includes granules, specific counter-ion
condensation, cononsolvency, dynamics in composition
and pH, effects of molecular crowding.
Binding and interaction of membranes with cytoskeleton.
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models, computer simulation, and experimental studies. On
the other side, chemists are able to synthesize highly
advanced materials with dynamic control of attached ligands
(“molecular surgery”8) and can monitor the transport of
complex materials through biological membranes.76 Even
the molecular details of the immune response induced by
polymer-based coatings and proteins have recently been
more clearly defined.88 For further progress in the design
flow between theory and in vitro testing, we emphasize the
potential to close missing links between model systems and
the biological context. Theoretical and experimental model
systems may systematically include next levels of complex-
ity: active components such as enzymes, solvent complexity
and cosolvency, the nano-object’s interplay with proteins by
means of protein corona and curvature-inducing proteins, the
variation of membrane tension, coupling to the cytoskeleton,
and the lateral structure of multicomponent membranes.
Systematically designed model experiments may receive
more emphasize before the in vitro testing of newly synthe-
sized materials. For example, existing theoretical models for
adhesion- and tension-dependent wrapping have not been
extensively tested yet in model experiments. An interesting
phenomenon to understand on a physical molecular level
will be the membrane fission event during endocytosis. We
illustrate the importance of integrating the existing knowl-
edge on membrane fusion, vesicle formation by membrane
fission, and vesicle transport into a complete picture of the
whole endocytic/exocytic cycle. Precisely determining the
topological pathway of a nano-object is crucial for knowing
which sensitive parts of a cell, e.g., DNA, are exposed to the
object for causing potentially toxic effects. It is important
not to over-define the targeted functionality, and to avoid
aiming for multifunctionality. Instead, it would be advanta-
geous to require the nanomaterial to be as minimally specific
as necessary in order to act as delivery vector, nanosensor,
or imaging agent. Finally, we close by throwing two chal-
lenging questions: Can we create a synthetic analog of a
complete endocytic cycle? Can we adapt a synthetic analog
of active ion transporters for direct translocation of nano-
objects?
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